| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |